Whereas the IDH subgroup has been singled out in many studies because of its distinct better patient survival and lower tumor proliferation rate [21], the lack of clustering of PDGFRA and especially of EGFRm with other RTK subgroups is surprising. The gene discussed is PDGFRA; the disease is neoplasm.